CDSCO approves AstraZeneca’s anti-complement medicine Eculizumab EP News Bureau Jan 17, 2025 Eculizumab is approved in India to manage two rare diseases- Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic…
